top of page

A Girls How To Guide

Search

Salesforce adds tools to identify at-risk patients to Health Cloud

Salesforce adds tools to identify at-risk patients to Health Cloud

Salesforce adds tools to identify at-risk patients to Health Cloud

Safi Bello

Feb 20, 20171 min read

IBM Watson Health Value-Based Care Solutions Debut at HIMSS17

IBM Watson Health Value-Based Care Solutions Debut at HIMSS17

IBM Watson Health Value-Based Care Solutions Debut at HIMSS17

Safi Bello

Feb 20, 20171 min read

DuPont settles fluorinated chemical lawsuits

DuPont settles fluorinated chemical lawsuits

DuPont settles fluorinated chemical lawsuits

Safi Bello

Feb 16, 20171 min read

World’s First Medically-Accurate Health Monitoring System Integrated in a Smartphone Now Readied For

World’s First Medically-Accurate Health Monitoring System Integrated in a Smartphone Now Readied For

World’s First Medically-Accurate Health Monitoring System Integrated in a Smartphone Now Readied For

Safi Bello

Feb 16, 20171 min read

FDA Approves New Psoriasis Drug

FDA Approves New Psoriasis Drug

FDA Approves New Psoriasis Drug

Safi Bello

Feb 16, 20171 min read

Baxter Reports 2016 Fourth-Quarter and Full-Year Results

Baxter Reports 2016 Fourth-Quarter and Full-Year Results

Baxter Reports 2016 Fourth-Quarter and Full-Year Results

Safi Bello

Feb 16, 20171 min read

Trump administration rule aims to tighten enrollment in ACA exchange plans

Trump administration rule aims to tighten enrollment in ACA exchange plans

Trump administration rule aims to tighten enrollment in ACA exchange plans

Safi Bello

Feb 15, 20171 min read

Price delays rule meant to encourage sharing of substance abuse treatment records

Price delays rule meant to encourage sharing of substance abuse treatment records

Price delays rule meant to encourage sharing of substance abuse treatment records

Safi Bello

Feb 15, 20171 min read

Device emulates human kidney function

Device emulates human kidney function

Device emulates human kidney function

Safi Bello

Feb 15, 20171 min read

Amgen Submits Supplemental Biologics License Application For BLINCYTO® (Blinatumomab) In Relapsed Or

Amgen Submits Supplemental Biologics License Application For BLINCYTO® (Blinatumomab) In Relapsed Or

Amgen Submits Supplemental Biologics License Application For BLINCYTO® (Blinatumomab) In Relapsed Or

Safi Bello

Feb 15, 20171 min read

Follow Us

bottom of page